Deferred Tax Assets, Gross of NEUROONE MEDICAL TECHNOLOGIES Corp from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Dec 2016 to 30 Sep 2025.
NEUROONE MEDICAL TECHNOLOGIES Corp Deferred Tax Assets, Gross for the quarter ending 30 Sep 2025 was $20,567,000, a 7.3% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Gross, Quarterly (USD)

Deferred Tax Assets, Gross, YoY Quarterly Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Deferred Tax Assets, Gross (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$20,567,000	+$1,402,000	+7.3%	30 Sep 2025	10-K	17 Dec 2025	2025	FY
Q3 2024	$19,165,000	+$3,532,000	+23%	30 Sep 2024	10-K	17 Dec 2025	2025	FY
Q3 2023	$15,633,000	+$3,575,000	+30%	30 Sep 2023	10-K	17 Dec 2024	2024	FY
Q3 2022	$12,058,000	+$3,185,482	+36%	30 Sep 2022	10-K	15 Dec 2023	2023	FY
Q3 2021	$8,872,518	+$3,177,944	+56%	30 Sep 2021	10-K	22 Dec 2022	2022	FY
Q3 2020	$5,694,574	+$1,743,366	+44%	30 Sep 2020	10-K/A	31 May 2022	2021	FY
Q3 2019	$3,951,208	+$1,835,940	+87%	30 Sep 2019	10-K	09 Dec 2020	2020	FY
Q3 2018	$2,115,268			30 Sep 2018	10-K	20 Dec 2019	2019	FY
Q4 2017	$1,105,877	+$999,845	+943%	31 Dec 2017	10-KT	18 Mar 2019	2018	FY
Q4 2016	$106,032			31 Dec 2016	10-K	16 Apr 2018	2017	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.